Try it
Dermatology · Leprosy: rifampicin and oral contraceptives
Sample itemA young woman on multibacillary therapy for leprosy is using combined oral contraceptive pills. What advice is correct?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Rifampicin induces liver enzymes and can lower pill efficacy, so add a barrier method
Rifampicin is a strong inducer of cytochrome P450 enzymes and increases the metabolism of oestrogens and progestogens, which can cause contraceptive failure. An additional barrier method is advised during treatment.
Option by option
A. The pill is unaffected by the antileprosy drugs, so no change is needed
This is wrong because rifampicin has a well-known interaction with hormonal contraceptives.
B. Rifampicin induces liver enzymes and can lower pill efficacy, so add a barrier method (correct)
Correct. Enzyme induction by rifampicin can reduce contraceptive efficacy.
C. Clofazimine raises oestrogen levels, so the pill dose should be halved
Clofazimine does not raise oestrogen levels, and no pill dose halving is advised.
D. Dapsone makes the pill unsafe, so it must be stopped for life
Dapsone does not make oral contraceptives unsafe and does not require lifelong cessation.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Dermatology questions
- Blistering disordersA patient has flaccid blisters that rupture easily and a positive Nikolsky sign. Which c…
- LeprosyIn which type of leprosy is the lepromin test strongly positive?
- Pigmentary disordersA man has well-demarcated chalk-white macules on his hands and around his mouth. A skin…
- Drug reactionsWhich of the following drugs is a well-recognised trigger of Stevens–Johnson syndrome an…